跳至主要内容
临床试验/JPRN-UMIN000019310
JPRN-UMIN000019310已完成未知

Randomized controlled study for concomitant use of 5-aminosalicylic acid suppository with increased dose of oral 5-aminosalicylic acid for moderate to severe patients with ulcerative colitis - Randomized controlled study for concomitant use of 5-ASA suppository with increased dose of oral 5-ASA for moderate to severe patients with ulcerative colitis

Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine0 个研究点目标入组 90 人开始时间: 2015年11月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Coexisting infectious colitis History of administrating more than 3.0 g of oral 5-ASA, topical 5-ASA, oral corticosteroid, tacrolimus before 30 days of enrollment History of receiving anti-TNF therapy before 60 days of enrollment Regularly administrating NSAIDs before 7 days of enrollment History of administrating topical corticosteroid before 7 days of enrollment Severe renal/liver dysfunction History of allergy for 5-ASA Concomitant malignant disease With pregnancy or lactation Judged as inadequate for this study by the researchers

研究者

发起方
Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine

相似试验